MethyLight: a High-throughput Assay to Measure DNA Methylation

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2000 Mar 29

PMID 10734209

Citations 530

Authors

C A Eads

K D Danenberg

K Kawakami

L B Saltz

C Blake

D Shibata

P V Danenberg

P W Laird

Affiliations

Soon will be listed here.

Abstract

Cytosine-5 DNA methylation occurs in the context of CpG dinucleotides in vertebrates. Aberrant methylation of CpG islands in human tumors has been shown to cause transcriptional silencing of tumor-suppressor genes. Most methods used to analyze cytosine-5 methylation patterns require cumbersome manual techniques that employ gel electrophoresis, restriction enzyme digestion, radiolabeled dNTPs or hybridization probes. The development of high-throughput technology for the analysis of DNA methylation would significantly expand our ability to derive molecular information from clinical specimens. This study describes a high-throughput quantitative methylation assay that utilizes fluorescence-based real-time PCR (TaqMan) technology that requires no further manipulations after the PCR step. MethyLight is a highly sensitive assay, capable of detecting methylated alleles in the presence of a 10,000-fold excess of unmethylated alleles. The assay is also highly quantitative and can very accurately determine the relative prevalence of a particular pattern of DNA methylation. We show that MethyLight can distinguish between mono-allelic and bi-allelic methylation of the MLH1 mismatch repair gene in human colorectal tumor specimens. The development of this technique should considerably enhance our ability to rapidly and accurately generate epigenetic profiles of tumor samples.

Citing Articles

Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective.

Mishra S, Kumari S, Husain N J Liq Biopsy. 2025; 6:100280.

PMID: 40027313 PMC: 11863890. DOI: 10.1016/j.jlb.2024.100280.

Genetic-epigenetic interactions (meQTLs) in orofacial clefts etiology.

Machado-Paula L, Romanowska J, Lie R, Hovey L, Doolittle B, Awotoye W medRxiv. 2025; .

PMID: 39990564 PMC: 11844571. DOI: 10.1101/2025.02.09.25321494.

Clinical promise and applications of epigenetic biomarkers.

Wisman G, Wojdacz T, Altucci L, Rots M, DeMeo D, Snieder H Clin Epigenetics. 2024; 16(1):192.

PMID: 39732727 PMC: 11682640. DOI: 10.1186/s13148-024-01806-8.

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.

Madan E, Palma A, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J Nat Biotechnol. 2024; .

PMID: 39653752 DOI: 10.1038/s41587-024-02453-3.

Multiplex digital profiling of DNA methylation heterogeneity for sensitive and cost-effective cancer detection in low-volume liquid biopsies.

Zhao Y, OKeefe C, Hu J, Allan C, Cui W, Lei H Sci Adv. 2024; 10(47):eadp1704.

PMID: 39576863 PMC: 11584010. DOI: 10.1126/sciadv.adp1704.

References

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Eads C, Danenberg K, Kawakami K, Saltz L, Danenberg P, Laird P . CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 1999; 59(10):2302-6. View

Frommer M, McDonald L, Millar D, Collis C, Watt F, GRIGG G . A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992; 89(5):1827-31. PMC: 48546. DOI: 10.1073/pnas.89.5.1827. View

Wolff R, Frazer K, Jackler R, Lanser M, Pitts L, Cox D . Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet. 1992; 51(3):478-85. PMC: 1682717. View

Thibodeau S, Bren G, Schaid D . Microsatellite instability in cancer of the proximal colon. Science. 1993; 260(5109):816-9. DOI: 10.1126/science.8484122. View

Lee L, Connell C, Bloch W . Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993; 21(16):3761-6. PMC: 309885. DOI: 10.1093/nar/21.16.3761. View

Issa J, Ottaviano Y, Celano P, Hamilton S, Davidson N, Baylin S . Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994; 7(4):536-40. DOI: 10.1038/ng0894-536. View

Livak K, Flood S, Marmaro J, Giusti W, Deetz K . Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995; 4(6):357-62. DOI: 10.1101/gr.4.6.357. View

Parsons R, Myeroff L, Liu B, WILLSON J, Markowitz S, Kinzler K . Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 1995; 55(23):5548-50. View

10.

Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996; 93(18):9821-6. PMC: 38513. DOI: 10.1073/pnas.93.18.9821. View

11.

Heid C, Stevens J, Livak K, Williams P . Real time quantitative PCR. Genome Res. 1996; 6(10):986-94. DOI: 10.1101/gr.6.10.986. View

12.

Gibson U, Heid C, Williams P . A novel method for real time quantitative RT-PCR. Genome Res. 1996; 6(10):995-1001. DOI: 10.1101/gr.6.10.995. View

13.

Kane M, Loda M, Gaida G, Lipman J, Mishra R, Goldman H . Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997; 57(5):808-11. View

14.

Gonzalgo M, Jones P . Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 1997; 25(12):2529-31. PMC: 146734. DOI: 10.1093/nar/25.12.2529. View

15.

Xiong Z, Laird P . COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997; 25(12):2532-4. PMC: 146738. DOI: 10.1093/nar/25.12.2532. View

16.

Ahuja N, Mohan A, Li Q, Stolker J, Herman J, Hamilton S . Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 1997; 57(16):3370-4. View

17.

Warnecke P, Stirzaker C, Melki J, Millar D, Paul C, Clark S . Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res. 1997; 25(21):4422-6. PMC: 147052. DOI: 10.1093/nar/25.21.4422. View

18.

Gonzalgo M, Bender C, You E, Glendening J, Flores J, Walker G . Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res. 1997; 57(23):5336-47. View

19.

Bender C, Pao M, Jones P . Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 1998; 58(1):95-101. View

20.

Herman J, Umar A, Polyak K, Graff J, Ahuja N, Issa J . Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998; 95(12):6870-5. PMC: 22665. DOI: 10.1073/pnas.95.12.6870. View